Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 67 (1), 40-45
- https://doi.org/10.1016/s0015-0282(97)81853-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Gonadotropin-releasing hormone agonists: Strategies formanaging the hypoestrogenic effects of therapyAmerican Journal of Obstetrics and Gynecology, 1992
- Hormone treatment of endometriosis: The estrogenthreshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1992
- Org OD 14 and the endometriumMaturitas, 1991
- Short-term effects of Org OD 14 and 17β-oestradiol on bone and lipid metabolism in early postmenopausal womenMaturitas, 1991
- Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1990
- A Comparison of the Skeletal Effects of Goserelin and Danazol in Premenopausal Women with EndometriosisHormone Research, 1989
- Treatment of climacteric complaints with ORG OD 14: A comparative study with oestradiol valerate and placeboMaturitas, 1988
- Benefits and risks of different hormonal replacement therapies in post-menopausal womenMaturitas, 1986
- Assessment of synthetic steroid (Org OD 14): Effect on skeletal metabolism by 24-h whole-body retention of diphosphonateMaturitas, 1981